Yumanity Therapeutics, Inc. YMTX
1.89 0.00 (+0.00%)
At closeDec 19, 2022, 12:00 AM EST
1.40 Day range 1.89
52-week range unavailable
Financial health
Altman Z-Score
-21.89 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -1.3×
FY 2024 5y median -1.3× FY 2024
P/S 0.0×
FY 2024 5y median 0.0× FY 2024
P/B -1.9×
FY 2024 5y median -1.9× FY 2024
P/FCF -2.0×
FY 2024 5y median -2.0× FY 2024
EV/EBITDA -1.7×
FY 2024 5y median -1.7× FY 2024
EV/Sales 0.0×
FY 2024 5y median 0.0× FY 2024
FCF Yield -50.6%
FY 2024 5y median -50.6% FY 2024
Profitability
Gross Margin 0.0%
FY 2024 5y median 0.0% FY 2024
Operating Margin 0.0%
FY 2024 5y median 0.0% FY 2024
Net Margin 0.0%
FY 2024 5y median 0.0% FY 2024
ROE 142.4%
FY 2024 5y median 142.4% FY 2024
ROIC 120.4%
FY 2024 5y median 120.4% FY 2024
ROA -1681.3%
FY 2024 5y median -1681.3% FY 2024
Growth (YoY)
Revenue 0.0%
FY 2024 FY 2024
Operating Income 0.0%
FY 2024 FY 2024
EPS (diluted) 0.0%
FY 2024 FY 2024
Free Cash Flow 0.0%
FY 2024 FY 2024
Financial Health
Current Ratio 0.1×
FY 2024 5y median 0.1× FY 2024
Quick Ratio 0.1×
FY 2024 5y median 0.1× FY 2024
Debt / Equity -0.1×
FY 2024 5y median -0.1× FY 2024
Net Debt / EBITDA 0.0×
FY 2024 5y median 0.0× FY 2024
Interest Coverage -98.1×
FY 2024 5y median -98.1× FY 2024
Dividends
Dividend Yield 0.0%
FY 2024 5y median 0.0% FY 2024
Payout Ratio 0.0%
FY 2024 5y median 0.0% FY 2024
Annual · latest fiscal year ends 2024-12-31